Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial.
about
Homocysteine-lowering interventions for preventing cardiovascular eventsInterventions for lowering plasma homocysteine levels in dialysis patientsEndophenotypes in Schizophrenia for the Perinatal Period: Criteria for Validation.Correlations between plasma homocysteine and folate concentrations and carotid atherosclerosis in high-risk individuals: baseline data from the Homocysteine and Atherosclerosis Reduction Trial (HART).Association between homocysteinemia and metabolic syndrome in patients with cardiovascular diseaseMeta-analysis: folic acid in the chemoprevention of colorectal adenomas and colorectal cancer.Dietary supplement use and colorectal cancer risk: a systematic review and meta-analyses of prospective cohort studies.Homocysteine-lowering interventions for preventing cardiovascular events.2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Reply to Lucock et al.: Significance of interpretation and misinterpretation of a small mechanistic study.Homocysteine is a bystander for ST-segment elevation myocardial infarction: a case-control study.
P2860
Q24186605-9DCBF256-523F-47FF-AC54-54B9F61CCA85Q26471859-F56A834C-D454-4EBE-AE67-4534B7935905Q30380523-EFD2D9B9-5697-4F79-89AA-3D372226B90FQ33378416-4CB0B36F-5EBC-4925-A6E0-41EC19817E9AQ36663682-04AA8C2B-49A0-4284-9059-B678EA5FE504Q37677813-D46ADDB9-D5D2-474D-B600-C46E9DE92C46Q38261818-19754880-0F99-45CF-AACC-208DEB730EB1Q38620630-9E2D8BAD-7925-4D16-836A-0E7BEAAEF8F6Q39007230-A7C5FDF7-C4DA-4ECD-B83A-7503486DB961Q39007236-73042677-E5E9-4249-82C5-20B066D6B0B4Q45233416-20FD25D7-67DF-4B0F-8E48-3AB91599B49EQ50058090-ACEBCB89-B2CD-46F8-B13A-BA482DC7AD1A
P2860
Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Rationale, design and baseline ...... ion Evaluation (HOPE)-2 trial.
@en
type
label
Rationale, design and baseline ...... ion Evaluation (HOPE)-2 trial.
@en
prefLabel
Rationale, design and baseline ...... ion Evaluation (HOPE)-2 trial.
@en
P2093
P2860
P921
P1476
Rationale, design and baseline ...... ion Evaluation (HOPE)-2 trial.
@en
P2093
HOPE-2 Investigators
J M O Arnold
J Probstfield
P Sheridan
P2860
P356
10.1016/S0828-282X(06)70238-0
P50
P577
2006-01-01T00:00:00Z